NVP ADW 742
Tocris Bioscience, part of Bio-Techne | Catalog # 5247
ATP-competitive inhibitor of IGF1R
Key Product Details
Description
ATP-competitive inhibitor of IGF1R
Product Description
NVP ADW 742 is an ATP-competitive inhibitor of IGF1R (IC50 in the range of 0.1-0.2 μM). Also inhibits c-Kit kinase activity (IC50 in the range of 3-5 μM). Exhibits a synergistic effect with Imatinib (Cat. No. 5906), enhancing the sensitivity of multiple small cell lung cancer cell lines to the chemotherapeutics Etoposide (Cat. No. 1226) and Carboplatin (Cat. No. 2626).Product Specifications
Molecular Weight
453.58
Formula
C28H31N5O
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
5-[3-(Phenylmethoxy)phenyl]-7-[trans-3-(1-pyrrolidinylmethyl)cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS Number
475488-23-4
PubChem ID
9825149
InChI Key
LSFLAQVDISHMNB-UHFFFAOYSA-N
SMILES
NC1=NC=NC2=C1C(C4=CC(OCC5=CC=CC=C5)=CC=C4)=CN2[C@@H]3C[C@@H](CN6CCCC6)C3
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 22.68 | 50 | |
| Ethanol | 4.54 | 10 |
Preparing Stock Solutions
for NVP ADW 742
The following data is based on the product molecular weight 453.58
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.5 mM | 4.41 mL | 22.05 mL | 44.09 mL |
| 2.5 mM | 0.88 mL | 4.41 mL | 8.82 mL |
| 5 mM | 0.44 mL | 2.20 mL | 4.41 mL |
| 25 mM | 0.09 mL | 0.44 mL | 0.88 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Warshamana-Greene The Ins-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling. Mol.Cancer Ther. 2004 PMID: 15141010
- Zhou The Ins-like growth factor-I receptor kinase inhibitor NVP-ADW742 sensitizes medulloblastoma to the effects of chemotherapy. Oncol. Rep. 2011 PMID: 21455580
- Warshamana-Greene The Ins-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy. Clin.Cancer Res. 2005 PMID: 15746061
Product Specific Notices for NVP ADW 742
For research use only
Loading...
Loading...